辐射研究与辐射工艺学报
輻射研究與輻射工藝學報
복사연구여복사공예학보
JOURNAL OF RADIATION RESEARCH AND RADIATION PROCESSING
2000年
2期
91-95
,共5页
郑秀龙%孟祥顺%赵芳%李雨%高建国
鄭秀龍%孟祥順%趙芳%李雨%高建國
정수룡%맹상순%조방%리우%고건국
新型乏氧放射增敏剂%甘氨双唑钠%4种肿瘤模型%CFU-GM
新型乏氧放射增敏劑%甘氨雙唑鈉%4種腫瘤模型%CFU-GM
신형핍양방사증민제%감안쌍서납%4충종류모형%CFU-GM
Novel hypoxic radiosensitizer%Sodium Glycididazole%Four tumor models%CFU-GM
采用4种不同肿瘤模型的荷瘤小鼠,观察了CMNa对受照小鼠肿瘤的作用.结果表明:与单纯照射组相比,CMNa能明显地减慢肿瘤的生长速度; 增加肿瘤生长的延迟天数,4种肿瘤模型均得到相同的结果.绝大多数SER值在1.3 以上.实验结果表明,CMNa对体内肿瘤亦有明显的放射增敏作用.然而在相似条件下,以CFU-GM为指标,在研究CMNa对受照正常小鼠对射线敏感的造血组织有否影响时,却未观察到CMNa对正常组织的放射增敏效应,与单纯照射组相比,CFU-GM无变化,SER=1,其治疗增益指数(TGF)均在1.3以上.提示:CMNa将有希望成为临床肿瘤治疗有效的新型放疗增敏药.
採用4種不同腫瘤模型的荷瘤小鼠,觀察瞭CMNa對受照小鼠腫瘤的作用.結果錶明:與單純照射組相比,CMNa能明顯地減慢腫瘤的生長速度; 增加腫瘤生長的延遲天數,4種腫瘤模型均得到相同的結果.絕大多數SER值在1.3 以上.實驗結果錶明,CMNa對體內腫瘤亦有明顯的放射增敏作用.然而在相似條件下,以CFU-GM為指標,在研究CMNa對受照正常小鼠對射線敏感的造血組織有否影響時,卻未觀察到CMNa對正常組織的放射增敏效應,與單純照射組相比,CFU-GM無變化,SER=1,其治療增益指數(TGF)均在1.3以上.提示:CMNa將有希望成為臨床腫瘤治療有效的新型放療增敏藥.
채용4충불동종류모형적하류소서,관찰료CMNa대수조소서종류적작용.결과표명:여단순조사조상비,CMNa능명현지감만종류적생장속도; 증가종류생장적연지천수,4충종류모형균득도상동적결과.절대다수SER치재1.3 이상.실험결과표명,CMNa대체내종류역유명현적방사증민작용.연이재상사조건하,이CFU-GM위지표,재연구CMNa대수조정상소서대사선민감적조혈조직유부영향시,각미관찰도CMNa대정상조직적방사증민효응,여단순조사조상비,CFU-GM무변화,SER=1,기치료증익지수(TGF)균재1.3이상.제시:CMNa장유희망성위림상종류치료유효적신형방료증민약.
The aim of this study was to see whether Sodium Glycididazole (CMNa) could enhance the in situ tumor efficacy ofradiation,using 4 different tumor models bearing mice.The results showed that incomparison with the irradiated group alone,CMNa could decrease the velocity of tumorgrowth and increase the days of Tumor Growth Delay(TGD) evidently in all four tumortypes.CMNa showed radiosensitizing activity for all tumors with SERs greater than1.3.It demonstrates that the novel radiosensitizer can potentiate the in situanti-tumor efficacy of radiation and has different radiosensitization effect amongthe tested tumors.Whether the new radiosensitizer CMNa has any effects on normaltissue such as radiosensitive bone marrow was tested.Survival of bonemarrow stemcells(CFU-GM) due to radiation alone or in combination with the drug was assessed.Nevertheless it did not enhance the radiosensitizing effect on normal bonemarrow and SER=1.The Therapeutic Gain Factor(TGF) defined as SER of tumor divided by SER of normaltissue bone marrow is greater than 1.3.Maybe CMNa will be an effective new typeradiosensitive drug for clinical cancer therapy.